General considerations for proteolytic cascades

Biochemical Society Transactions

Volumn 32, Issue 1, 2004, Pages 15-16

  Amour, A ^a   Bird, M ^a   Chaudry, L ^a   Deadman, J ^b,e   Hayes, D ^c   Kay, C ^d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^c Upstate Ltd   (United Kingdom)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Zenyth Therapeutics Limited Australia   (Australia)

Author keywords

Blood coagulation; Caspase; Complement; Matrix metalloproteinase; Protease; Proteolytic cascade

Indexed keywords

MATRIX METALLOPROTEINASE;

APOPTOSIS; BLOOD CLOTTING; CONFERENCE PAPER; HUMAN; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS;

BLOOD COAGULATION; DRUG DESIGN; ENDOPEPTIDASES; HUMANS; PROTEASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 1442309701     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0320015     Document Type: Conference Paper

References (11)

1. Southan, C. (2001) Drug Discovery Today 6, 681-688
2. Reference deleted
3. Barrett, A.J., Rawlings, N.D. and Woessner, J.F. (1998) Handbook of Proteolytic Enzymes, Academic Press, New York
4. Hockin, M.F. Jones, K.C., Everse, S.J. and Mann, K.G. (2002) J. Biol. Chem. 277, 18322-18333
5. Rosenberg, R.D. (1989) Am. J. Med. 87, 25-95
6. Stone, S.R. and Tapparelli, C. (1995) J. Enzyme inhib. 9, 3-15
7. Havsteen, B.H. and Varon, R. (1990) J. Theor. Biol. 145, 47-64
8. Banner, D.W., D'Arcy, A., Chene, C., Winkler, F.K., Guha, A., Konigsberg, W.H., Nemerson, Y. and Kirchhofer, D. (1996) Nature (London) 380, 41-46
9. Jones, K.C. and Mann, K.G. (1994) J. Biol. Chem. 269, 23367-23373
10. Wieland, H.A., Laux, V., Kozian, D. and Lorenz, M. (2003) Curr. Opin. Invest. Drugs 4, 264-271
11. Mortimore, M. (2000) Chem. Biol. 7, 423-432